glycidyl trimethylammonium chloride has been researched along with Extravascular Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rekha, MR; Sharma, CP; Thomas, JJ | 1 |
| Cavallaro, G; Duncan, R; Giammona, G; Pedone, E; Richardson, SC | 1 |
2 other study(ies) available for glycidyl trimethylammonium chloride and Extravascular Hemolysis
| Article | Year |
|---|---|
Dextran-glycidyltrimethylammonium chloride conjugate/DNA nanoplex: A potential non-viral and haemocompatible gene delivery system.
Topics: Animals; Cattle; Dextrans; DNA; Epoxy Compounds; Gene Transfer Techniques; Genetic Vectors; Hemolysis; Hep G2 Cells; Humans; Nanoparticles; Quaternary Ammonium Compounds; Transfection | 2010 |
alpha,beta-poly(asparthylhydrazide)-glycidyltrimethylammonium chloride copolymers (PAHy-GTA): novel polymers with potential for DNA delivery.
Topics: Animals; DNA; Endodeoxyribonucleases; Epoxy Compounds; Genetic Therapy; Hemolysis; Male; Mice; Peptides; Polymers; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Tissue Distribution; Transfection; Tumor Cells, Cultured | 2001 |